Concepedia

Chloé C. Lefebvre

CC

Statistics

Publications

2

Citations

37

H-Index

2

Active since

2022

Affiliations

Centre National de la Recherche Scientifique(Current)

Nantes Université

Institut Génétique Nantes Atlantique

Institut de Recherche en Génie Civil et Mécanique

Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers

Chloé C. Lefebvre is an author at Centre National de la Recherche Scientifique specializing in pharmacological disruption, bh3 mimetic compounds, and mcl-1 function.

ORCID

Publications per year

2022–2024

2

Publications

2

Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties

Thomas L. Bonneaud, Chloé C. Lefebvre, Lisa Nocquet et al. · Cell Death and Disease · 2022 · 21 citations · Full text

, , +17

Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts

Lisa Nocquet, Julie Roul, Chloé C. Lefebvre et al. · Scientific Reports · 2024 · 16 citations · Full text

, , +17

1–2 of 2